National Cancer Survivors Day Scheduled for June 2, 1996

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 3
Volume 5
Issue 3

FRANKLIN, Tenn--On Sunday, June 2, 1996, more than 600 communities throughout the United States will hold celebrations of life as part of the ninth annual National Cancer Survivors Day. The event recognizes the country's more than 8 million cancer survivors (2% of the population) and serves as a platform to call attention to the barriers that prevent many Americans from receiving state-of-the-art cancer treatment.

FRANKLIN, Tenn--On Sunday, June 2, 1996, more than 600 communitiesthroughout the United States will hold celebrations of life aspart of the ninth annual National Cancer Survivors Day. The eventrecognizes the country's more than 8 million cancer survivors(2% of the population) and serves as a platform to call attentionto the barriers that prevent many Americans from receiving state-of-the-artcancer treatment.

The event had its beginnings in Kansas City when cancer survivorRichard Bloch (co-founder of the tax service H&R Block) andhis wife, Annette, held their first Cancer Survivor Rally, toobtain media coverage that would demonstrate that a diagnosisof cancer is not an automatic death sentence.

Today, the event is presented by the nonprofit National CancerSurvivors Day Foundation, Richard and Annette Bloch, FoundingCo-Chairs, and is sponsored nationally by Coping magazine (a consumermagazine for people living with cancer), Glaxo Wellcome, JanssenPharmaceutica, and SmithKline Beecham Pharmaceuticals.

For information about the Survivors Day celebration in local communities,contact local hospitals or call Cindy Phiffer, director of mediarelations, phone/fax: 615-848-0503.

Recent Videos
Educating community practices on CAR T referral and sequencing treatment strategies may help increase CAR T utilization.
The FirstLook liquid biopsy, when used as an adjunct to low-dose CT, may help to address the unmet need of low lung cancer screening utilization.
An 80% sensitivity for lung cancer was observed with the liquid biopsy, with high sensitivity observed for early-stage disease, as well.
9 Experts are featured in this series.
9 Experts are featured in this series.
Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
2 experts are featured in this series.
Patients who face smoking stigma, perceive a lack of insurance, or have other low-dose CT related concerns may benefit from blood testing for lung cancer.
9 Experts are featured in this series.
Related Content